China Pharma logo

China Pharma Share Price Today

(NASDAQ: CPHI)

China Pharma share price is $0.2 & ₹17.39 as on 6 Mar 2025, 2.30 'hrs' IST

$0.2

Market is closed - opens 8 PM, 06 Mar 2025

View live China Pharma share price in Dollar and Rupees. Guide to invest in China Pharma stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in China Pharma, along with analyst recommendations, forecasts, and comprehensive financials.

China Pharma share price movements

  • Today's Low: $0.19
    Today's High: $0.20

    Day's Volatility :6.32%

  • 52 Weeks Low: $0.13
    52 Weeks High: $0.44

    52 Weeks Volatility :70.45%

China Pharma (CPHI) Returns

PeriodChina Pharma Holdings IncIndex (Russel 2000)
3 Months
4.34%
0.0%
6 Months
15.3%
0.0%
1 Year
-43.42%
0.0%
3 Years
-98.97%
-11.6%

China Pharma (CPHI) Key Statistics

in dollars & INR

Previous Close
$0.202
Open
$0.1959
Today's High
$0.2045
Today's Low
$0.191576
Market Capitalization
$3.7M
Today's Volume
$221.8K
52 Week High
$0.44
52 Week Low
$0.13
Revenue TTM
$6.2M
EBITDA
$-1.4M
Earnings Per Share (EPS)
$-0.69
Profit Margin
-70.49%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-74.89%

How to invest in China Pharma Stock (CPHI) from India?

It is very easy for Indian residents to invest directly in China Pharma from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the China Pharma stock in both Indian Rupees (INR) and US Dollars (USD). Search for China Pharma or CPHI on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of China Pharma or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of China Pharma shares which would translate to 4.348 fractional shares of China Pharma as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like China Pharma, in just a few clicks!

Returns in China Pharma (CPHI) for Indian investors in Rupees

The China Pharma stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

China Pharma investment value today

Current value as on today

₹60,518

Returns

₹39,482

(-39.48%)

Returns from China Pharma Stock

₹44,444 (-44.44%)

Dollar Returns

₹4,963 (+4.96%)

Indian investors sentiment towards China Pharma (CPHI)

27%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for China Pharma Stock from India on INDmoney has increased by 27% in the last 30 days, reflecting an upward trend in search activity.

Analyst Recommendation on China Pharma

Analyst Forecast on China Pharma Stock (CPHI)

What analysts predicted

Upside of 1400.0%

Target:

$3.00

Current:

$0.20

Insights on China Pharma Stock (Ticker Symbol: CPHI)

  • Price Movement

    In the last 3 years, CPHI stock has moved down by -99.0%
  • Increasing Revenue

    Revenue is up for the last 2 quarters, 924.94K → 1.10M (in $), with an average increase of 15.9% per quarter
  • Increasing Net Profit

    Netprofit is up for the last 2 quarters, -1.43M → -1.11M (in $), with an average increase of 28.6% per quarter
  • CPHI vs ITCI (1 yr)

    In the last 1 year, Intra-cellular Therapies, Inc. has given 97.0% return, outperforming this stock by 138.4%
  • CPHI vs ITCI (3 yr)

    In the last 3 years, Intra-cellular Therapies, Inc. has given 138.2% return, outperforming this stock by 237.2%
  • Price to Sales

    ForCPHI every $1 of sales, investors are willing to pay $0.3, whereas for Intra-cellular Therapies, Inc., the investors are paying $19.9 for every $1 of sales.

China Pharma Technicals Summary

Sell

Neutral

Buy

China Pharma is currently in a neutral trading position according to technical analysis indicators.

China Pharma (CPHI) Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
China Pharma Holdings Inc logo
-1.8%
15.3%
-43.42%
-98.97%
-99.41%
Intra-cellular Therapies, Inc. logo
3.42%
81.22%
98.76%
146.55%
588.92%
Haleon Plc Spon Ads logo
12.55%
3.39%
28.09%
43.99%
43.99%
Zoetis Inc. logo
-1.19%
-8.94%
-7.43%
-9.67%
30.97%
Neurocrine Biosciences Inc. logo
-24.64%
-6.68%
-14.47%
28.61%
27.88%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
China Pharma Holdings Inc logo
NA
NA
0.0
0.0
-0.75
-0.18
NA
0.7
Intra-cellular Therapies, Inc. logo
NA
NA
0.0
0.13
-0.09
-0.07
NA
10.81
Haleon Plc Spon Ads logo
26.68
26.68
1.5
0.36
0.09
0.04
0.02
1.8
Zoetis Inc. logo
31.17
31.17
3.01
6.07
0.51
0.15
0.01
10.64
Neurocrine Biosciences Inc. logo
34.8
34.8
0.27
6.47
0.14
0.1
NA
26.05
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
China Pharma Holdings Inc logo
NA
$3.7M
-99.41%
NA
-70.49%
Intra-cellular Therapies, Inc. logo
Buy
$14.0B
588.92%
NA
-10.97%
Haleon Plc Spon Ads logo
Buy
$48.2B
43.99%
26.68
12.84%
Zoetis Inc. logo
Buy
$76.1B
30.97%
31.17
26.86%
Neurocrine Biosciences Inc. logo
Buy
$11.3B
27.88%
34.8
14.49%

About China Pharma

China Pharma Holdings, Inc. develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products to hospitals and private retailers in the People's Republic of China. The company provides products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. Its products include Cerebroprotein Hydroloysate injection to treat memory decline and attention deficit; Gastrodin injection for tiredness, loss of concentration, poor sleep, and traumatic syndromes of the brain; Propylgallate injection to treat cerebral thrombosis, coronary heart disease, and after surgery complications; Ozagrel Sodium to treat acute thrombotic cerebral infarction and dyskinesia; Alginic Sodium Diester injection for ischemic heart, cerebrovascular, and high lipoprotein blood diseases; Bumetanide injection to treat edema diseases; and Candesartan for hypertension. In addition, the company provides Roxithromycin dispersible tablets for pharyngitis and tonsillitis; Cefaclor dispersible tablets for tympanitis, lower respiratory tract infection, urinary tract infections, and skin/skin tissue infection; Cefalexin capsules for acute tonsillitis; Andrographolide for sore throat caused by upper respiratory tract infection; Clarithromycin granules and capsules; and Naproxen Sodium and PseudophedrineHydrochlorida sustained release tablets. Further it offers Hepatocyte growth-promoting factor, Tiopronin, Compound Ammonium Glycyrrhetate S, and Omeparzole for the treatment of digestive diseases. Additionally, the company provides Vitamin B6 injection; Granisetron Hydrochloride injection to treat nausea and vomiting caused by radiotherapy and chemotherapy during the treatment of malignant tumors; Noni Enzyme, a food supplement; sanitizers; and masks. It offers its products through distributors, its network of sales offices, and sales representatives. The company is based in Haikou, the People's Republic of China.
Organization
China Pharma
Employees
231
CEO
Ms. Zhilin Li
Industry
Health Technology

Management People of China Pharma

NameTitle
Ms. Zhilin Li
President, CEO, Chairman & Interim CFO
Ms. Huang Na C.F.A.
BOD Secretary & IR Manager

Important FAQs about investing in CPHI Stock from India :

What is China Pharma share price today?

China Pharma share price today stands at $0.20, Open: $0.20 ; Previous Close: $0.20 ; High: $0.20 ; Low: $0.19 ; 52 Week High: $0.44 ; 52 Week Low: $0.13.

The stock opens at $0.20, after a previous close of $0.20. The stock reached a daily high of $0.20 and a low of $0.19, with a 52-week high of $0.44 and a 52-week low of $0.13.

Can Indians buy China Pharma shares?

Yes, Indians can invest in the China Pharma (CPHI) from India.

With INDmoney, you can buy China Pharma at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy China Pharma at zero transaction cost.

How can I buy China Pharma shares from India?

It is very easy to buy China Pharma from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of China Pharma (CPHI) be purchased?

Yes, you can buy fractional shares of China Pharma with INDmoney app.

What are the documents required to start investing in China Pharma stocks?

To start investing in China Pharma, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of China Pharma Stock (CPHI)?

Today’s highest price of China Pharma (CPHI) is $0.20.

Today’s lowest price of China Pharma (CPHI) is $0.19.

What is today's market capitalisation of China Pharma?

Today's market capitalisation of China Pharma CPHI is 3.7M

What is the 52 Week High and Low Range of China Pharma Stock (CPHI)?

  • 52 Week High

    $0.44

  • 52 Week Low

    $0.13

What are the historical returns of China Pharma (CPHI)?

  • 1 Month Returns

    -1.8%

  • 3 Months Returns

    15.3%

  • 1 Year Returns

    -43.42%

  • 5 Years Returns

    -99.41%

Who is the Chief Executive Officer (CEO) of China Pharma ?

Ms. Zhilin Li is the current Chief Executive Officer (CEO) of China Pharma.